{"product_id":"global-vascular-embolization-market-size-study-forecast-by-product-embolic-agents-embolization-devices-by-application-oncology-peripheral-vascular-diseases-urology-and-nephrology-neurology-others-by-end-user-hospitals-and-clinics-ambulator","title":"Global Vascular Embolization Market Size study \u0026 Forecast, by Product (Embolic Agents, Embolization Devices), by Application (Oncology, Peripheral Vascular Diseases, Urology and Nephrology, Neurology, Others), by End User (Hospitals and Clinics, Ambulator","description":"\u003cp\u003eGlobal Vascular Embolization Market Size study \u0026amp; Forecast, by Product (Embolic Agents, Embolization Devices), by Application (Oncology, Peripheral Vascular Diseases, Urology and Nephrology, Neurology, Others), by End User (Hospitals and Clinics, Ambulatory Surgical Centers, Others) and Regional Analysis, 2022-2029\u003cbr\u003e\nGlobal Vascular Embolization Market is valued at approximately USD 3.7 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7.50% over the forecast period 2022-2029. Embolization is a minimally invasive treatment that blocks one or more blood vessels or abnormal vascular channels. And provide temporary or permanent relief of the condition by removing atypical blood vessel connections. The increasing prevalence of vascular diseases is anticipated to boost the Vascular Embolization Market throughout the forecast period of 2022-2029.\u003c\/p\u003e\n\n\u003cp\u003eThe increasing prevalence of vascular diseases and minimally invasive vascular procedures is one of the primary reasons for the growth of the Vascular Embolization Market. According to the World Health Organization, in 2020, 17.9 million people died from cardiovascular diseases worldwide. Additionally, 85% of these cardiovascular disease deaths are due to heart attack and stroke. For instance, according to the article published in Cureus Journal of Medical Science in July 2020, ischemic heart disease affects around 1,655 per 100,000 and is expected to exceed 1,845 per 1,00,000 by 2030.  Also, various new product launches by key players and increased investments by governments of various countries to improve healthcare infrastructure are anticipated demands in the forecast period. Moreover, technological advancements in embolization products and increasing research and development activities are the key driving factors in the global Vascular Embolization Market. However, the high cost associated with the procedures stifles market growth throughout the forecast period of 2022-2029.\u003c\/p\u003e\n\n\n\u003cp\u003eThe key regions considered for the Global Vascular Embolization Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue due to increasing research and development activities, increased vascular related diseases such as Cancer and brain aneurysm and increased research and development activities. Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising chronic diseases, surge in healthcare expenditure and growing awareness about vascular embolization, changing lifestyle, and increasing population in this region.\u003c\/p\u003e\n\n\u003cp\u003eMajor market player included in this report are:\u003cbr\u003e\nMedtronic PLC\u003cbr\u003e\nCook Medical\u003cbr\u003e\nStryker Corporation\u003cbr\u003e\nBoston Scientific Corporation\u003cbr\u003e\nAbbott Laboratories\u003cbr\u003e\nJohnson and Johnson (CERENOVUS) Private Limited,\u003cbr\u003e\nMerit Medical Systems Inc.\u003cbr\u003e\nPenumbra Inc.\u003cbr\u003e\nTerumo Medical Corporation\u003cbr\u003e\nShape Memory Medical Inc.\u003c\/p\u003e\n\n\u003cp\u003eRecent Developments in the Market:\u003cbr\u003e\nIn July 2021, Terumo Medical Corporation (TMC)released the AZUR Vascular Plug, the first plug compatible with a microcatheter.This can be used to slow or stop blood flow in arteries of the peripheral vasculature.\u003cbr\u003e\nIn April 2021, the US Food and Drug Administration (FDA) approved the Pipeline Flex Embolization Device with Shield Technology of Medtronic PLC, which was indicated primarily for brain aneurysms. Shield Technology enhances the flow diverter device by decreasing thrombogenicity caused due to the material.\u003c\/p\u003e\n\n\u003cp\u003eGlobal Vascular Embolization Market Report Scope:\u003cbr\u003e\nHistorical Data 2019-2020-2021\u003cbr\u003e\nBase Year for Estimation 2021\u003cbr\u003e\nForecast period 2022-2029\u003cbr\u003e\nReport Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends\u003cbr\u003e\nSegments Covered Product, Application, End User, Region\u003cbr\u003e\nRegional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World\u003c\/p\u003e\n\n\n\u003cp\u003eThe objective of the study is to define market sizes of different segments \u0026amp; countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.\u003c\/p\u003e\n\n\u003cp\u003eThe report also caters detailed information about the crucial aspects such as driving factors \u0026amp; challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:\u003cbr\u003e\nBy Product:\u003cbr\u003e\nEmbolic Agents\u003cbr\u003e\nEmbolization Devices\u003c\/p\u003e\n\n\u003cp\u003eBy Application:\u003cbr\u003e\nOncology\u003cbr\u003e\nPeripheral Vascular Diseases\u003cbr\u003e\nUrology and Nephrology\u003cbr\u003e\nNeurology\u003cbr\u003e\nOthers\u003c\/p\u003e\n\n\u003cp\u003eBy End user:\u003cbr\u003e\nHospitals and Clinics\u003cbr\u003e\nAmbulatory Surgical Centers\u003cbr\u003e\nOthers\u003c\/p\u003e\n\n\u003cp\u003eBy Region:\u003cbr\u003e\nNorth America\u003cbr\u003e\nU.S.\u003cbr\u003e\nCanada\u003cbr\u003e\nEurope\u003cbr\u003e\nUK\u003cbr\u003e\nGermany\u003cbr\u003e\nFrance\u003cbr\u003e\nSpain\u003cbr\u003e\nItaly\u003cbr\u003e\nROE\u003cbr\u003e\nAsia Pacific\u003cbr\u003e\nChina\u003cbr\u003e\nIndia\u003cbr\u003e\nJapan\u003cbr\u003e\nAustralia\u003cbr\u003e\nSouth Korea\u003cbr\u003e\nRoAPAC\u003cbr\u003e\nLatin America\u003cbr\u003e\nBrazil\u003cbr\u003e\nMexico\u003cbr\u003e\nRest of the World\u003c\/p\u003e\n\n\u003cp\u003eCompanies Mentioned\u003cbr\u003e\nMedtronic PLC\u003cbr\u003e\nCook Medical\u003cbr\u003e\nStryker Corporation\u003cbr\u003e\nBoston Scientific Corporation\u003cbr\u003e\nAbbott Laboratories\u003cbr\u003e\nJohnson and Johnson (CERENOVUS) Private Limited,\u003cbr\u003e\nMerit Medical Systems Inc.\u003cbr\u003e\nPenumbra Inc.\u003cbr\u003e\nTerumo Medical Corporation\u003cbr\u003e\nShape Memory Medical Inc.\u003c\/p\u003e\n\n\u003cp\u003ePlease note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"May, 2023 \/ 200 Pages \/ MCW16241334","offer_id":47657842311474,"sku":null,"price":5940.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-vascular-embolization-market-size-study-forecast-by-product-embolic-agents-embolization-devices-by-application-oncology-peripheral-vascular-diseases-urology-and-nephrology-neurology-others-by-end-user-hospitals-and-clinics-ambulator","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}